Active recombinant C3a of human anaphylatoxin produced in Escherichia coli
- 29 March 1991
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 175 (3), 1131-1138
- https://doi.org/10.1016/0006-291x(91)91683-4
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 11 references indexed in Scilit:
- [49] Human C5a anaphylatoxin: Gene synthesis, expression, and recovery of biologically active material from Escherichia coliMethods in Enzymology, 1988
- Anaphylatoxins: Possible Roles in DiseaseComplement (Basel, Switzerland), 1986
- Role of the N-terminal regions of hog C3a, C5a and C5a-desArg in their biological activitiesMolecular Immunology, 1986
- Slow reacting substance in the exudate of allergic air pouch inflammation in ratsProstaglandins, Leukotrienes and Medicine, 1983
- Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.The Journal of Experimental Medicine, 1982
- Isolation of three separate anaphylatoxins from complement-activated human serumMolecular and Cellular Biochemistry, 1981
- Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a)Inflammation, 1981
- Comparative study on biological effects of the guinea pig complement-peptide C3a and C3a-related synthetic oligopeptidesMolecular Immunology, 1980
- Anaphylatoxins: C3a and C5aAdvances in Immunology, 1978
- Induction of platelet aggregation by the complement-derived peptides C3a and C5aNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1976